Inflammasome develops combo HIV/birth control implant 23-Aug-2021 By Jenni Spinner Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.
UPDATED Boehringer in $160m deal with Inflammasome on intravitreal treatments 24-Sep-2019 By Vassia Barba Boehringer adopts Inflammasome’s intravitreal drug delivery technology to develop treatments for retinal diseases.